{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:37:44Z","timestamp":1761179864469,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"14-15","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":5539,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.micinf.2008.09.004","type":"journal-article","created":{"date-parts":[[2008,9,25]],"date-time":"2008-09-25T04:47:57Z","timestamp":1222318077000},"page":"1577-1581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection"],"prefix":"10.1016","volume":"10","author":[{"given":"Julia","family":"Vipond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin L.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Lambeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank E.","family":"Aldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2008.09.004_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jama.1995.03520270054031","article-title":"Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic","volume":"273","author":"Raviglione","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.micinf.2008.09.004_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2008.09.004_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette\u2013Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.micinf.2008.09.004_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0192-0561(94)90033-7","article-title":"BCG-induced mucosal immune responses","volume":"16","author":"Gheorghiu","year":"1994","journal-title":"Int. J. Immunopharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.micinf.2008.09.004_bib5","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1086\/313864","article-title":"Mucosal bacille Calmette\u2013Guerin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses","volume":"30","author":"Hoft","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micinf.2008.09.004_bib6","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/IAI.74.4.2449-2452.2006","article-title":"Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG Substrain Moreau Rio de Janeiro oral vaccine","volume":"74","author":"Cosgrove","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2008.09.004_bib7","first-page":"228","article-title":"Viability and multiplication of vaccines in immunization against tuberculosis","volume":"71","author":"Bloch","year":"1995","journal-title":"Am. Rev. Tuberc. Pulm. Dis."},{"key":"10.1016\/j.micinf.2008.09.004_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/IAI.71.1.101-108.2003","article-title":"Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice","volume":"71","author":"Aldwell","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2008.09.004_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1711.2005.01369.x","article-title":"Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity","volume":"83","author":"Aldwell","year":"2005","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.micinf.2008.09.004_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0264-410X(03)00539-5","article-title":"Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums","volume":"22","author":"Aldwell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2008.09.004_bib11","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.vaccine.2005.01.150","article-title":"Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis","volume":"23","author":"Buddle","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2008.09.004_bib12","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1128\/IAI.73.3.1903-1905.2005","article-title":"Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis","volume":"73","author":"Aldwell","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2008.09.004_bib13","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/IAI.00052-08","article-title":"Oral vaccination of guinea pigs with Mycobacterium bovis bacille Calmette\u2013Guerin (BCG) vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis","volume":"76","author":"Clark","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2008.09.004_bib14","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1128\/IAI.68.12.7094-7099.2000","article-title":"Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin","volume":"68","author":"Chambers","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2008.09.004_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000237618","article-title":"Oral immunization with poly-(d,l-lactide-co-glycolide) and poly-(l-lactic acid) microspheres containing pneumotropic bacterial antigens","volume":"113","author":"Kofler","year":"1997","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.micinf.2008.09.004_bib16","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0264-410X(99)00386-2","article-title":"Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice","volume":"18","author":"Lagranderie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2008.09.004_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00365540151060743","article-title":"Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis","volume":"33","author":"McMurray","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.micinf.2008.09.004_bib18","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus Calmette\u2013Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.micinf.2008.09.004_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/14760584.6.3.323","article-title":"A perspective of oral vaccination against bovine tuberculosis with Mycobacterium bovis BCG","volume":"6","author":"Cross","year":"2007","journal-title":"Expert. Rev. Vaccines"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645790800261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645790800261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:24:25Z","timestamp":1761143065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S128645790800261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":19,"journal-issue":{"issue":"14-15","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S128645790800261X"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2008.09.004","relation":{},"ISSN":["1286-4579"],"issn-type":[{"type":"print","value":"1286-4579"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2008.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}